Industry News
Medical Device Industry News
Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous clinical approach that raises throughput for fertility clinics, expands access, and empowers women to plan on their own terms.
CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation
In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at
Vektor Medical Announces Post-Market Study Evaluating Benefit of AI-Powered Analysis to Identify and Ablate Non-Pulmonary Vein AF Targets
vMap is the only FDA-cleared non-invasive AI-powered arrhythmia analysis technology designed to improve, enhance, and accelerate ablation procedures, utilizing data from a standard 12-lead ECG.
Announcing RED® 72 SILVER LABEL | Now Featuring Penumbra’s Latest Engineering Enhancements Designed for Seamless Navigation
The new RED 72 SILVER LABEL with SENDit® Technology has shown a remarkable 50% increase in trackability over the original RED 72 with SENDit Technology.
Global Trauma Devices Market Report by iData Research | Uncovers $1.5B Growth Opportunity Driven by Titanium Implants, Modular Systems, and Surgical Robotics
A new 2025 Global Trauma Devices Market Report reveals critical insights for orthopedic device executives, product strategists, and investors seeking to navigate pricing pressures, material innovations, and shifting surgical practices in the orthopedic trauma sector.
Four Sigmatic Debuts The Last of Us Organic Ground Coffee, Infected with Focus & Energy
Four Sigmatic, the #1 functional coffee brand, announced the debut of The Last Of Us High Caffeine Organic Ground Coffee in collaboration with Sony Pictures Consumer Products. Four Sigmatic’s The Last of Us coffee is
CereVasc’s eShunt® System Gains FDA Breakthrough Designation
"The recognition of Breakthrough Device Designation for the eShunt System in pediatric aged patients demonstrates the profound need for treatment innovation in this patient population and reinforces the potential safety and efficacy benefits that have
Efemoral Medical Releases Positive Long-Term Results from EFEMORAL I
"The EVSS represents a new paradigm in peripheral interventions," said Christopher Haig, Co-Founder and CEO of Efemoral Medical. "It's easy to deploy, has high radial strength, can be made in longer lengths, and offers the
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
Phasix™ ST Umbilical Hernia Patch leverages same surgical technique as permanent mesh procedures
Overcoming Taste and Texture Challenges In High-protein Snacks | By Jack Helm, Account Manager at Beverage, Bakery & Functional Snacks
Discover how to enhance taste and texture in high-protein snacks for better consumer appeal and satisfaction.
Boston Scientific Chief Financial Officer Dan Brennan to Retire | Jon Monson, SR VP, Investor Relations to succeed Brennan
Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.
Mursla Bio Receives FDA Breakthrough Device Designation for EvoLiver Test
Reflects the potential of EvoLiver test to improve early liver cancer detection among high-risk patients
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory ("EMBL"), and its technology transfer arm EMBLEM.
Adventist HealthCare Emergency Departments Launch AI Initiative to Help Enhance Patient Safety and Care Efficiency
The software, KATE AI, is helping care teams ensure the safety and consistency of triage at Adventist HealthCare Shady Grove Medical Center, Adventist HealthCare White Oak Medical Center and Adventist HealthCare Fort Washington Medical Center.
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDEÒ Drug Eluting Bioresorbable Scaffold
The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD, which according to the American Heart Association affects more than 200 million people globally, and 10 to 12 million in the
Climate-Controlled Field Hospitals: Protecting Patients in Extreme Environments
Climate-controlled field hospitals have emerged as critical innovations in humanitarian response, military operations, and disaster relief efforts. These sophisticated temporary facilities enable healthcare delivery in environments where temperatures soar above 120°F or plummet below freezing,
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from its market-leading Decipher Prostate Genomic Classifier are available in a new specialized database that the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology,
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe.
Paragonix Celebrates 100th Kidney Transplant Case with FDA-Cleared KidneyVault ™ System
This milestone was achieved with the support of Tennessee Donor Services (TDS), an Organ Procurement Organization (OPO) that serves more than 6 million people across Tennessee and Virginia.
ARUP Laboratories Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
As this biomarker can be detected in blood, this test is a minimally invasive and broadly accessible diagnostic tool that may facilitate earlier detection of AD.